 Vancomycin empirical combination antibiotic therapy fever granulocytopenic cancer patients European Organization Research Treatment Cancer EORTC International Antimicrobial Therapy Cooperative Group National Cancer Institute Canada-Clinical Trials Group erratum Infect Dis Oct total febrile granulocytopenic patients cancer ceftazidime amikacin CA vancomycin initial empirical therapy Single gram-positive bacteremias patients CA treated CAV single gram-negative bacteremias possible infections response rates CA CAV patients gram-positive bacteremia patients differences treatment regimens proportion febrile patients trial day duration fever patient gram-positive bacteremia first days true empirical therapy Antibiotic-associated nephrotoxicity frequent patients vancomycin results empirical addition vancomycin initial antibiotic therapy cancer patients fever granulocytopenia